HLA-A2.1/Kb Transgenic Murine Dendritic Cells Transduced with an Adenovirus Encoding Human gp100 Process the Same A2.1-Restricted Peptide Epitopes as Human Antigen-Presenting Cells and Elicit A2.1-Restricted Peptide-Specific CTL

This publication has 40 references indexed in Scilit:

• MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
  Annual Review of Immunology, 1998
• Cloning and Characterization of the Genes Encoding the Murine Homoloties of the Human Melanoma Antigens MARTI and gp100
  Journal of Immunotherapy, 1997
• Endogenous presentation of a nascent antigenic epitope to CD⁸⁺ CTL is more efficient than exogenous presentation
  Immunology & Cell Biology, 1996
• Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice
  European Journal of Immunology, 1996
• From defined human tumor antigens to effective immunization?
  Immunology Today, 1995
• Analysis of the fine specificity of rat, mouse and human TAP peptide transporters
  European Journal of Immunology, 1995
• Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
  Science, 1994
• Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation.
  The Journal of Experimental Medicine, 1991
• An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens
  Cell, 1985
• A Clonal Deletion Model for Ir Gene Control of the Immune Response
  Scandinavian Journal of Immunology, 1978